Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics.
CNS & Neurological Disorders - Drug Targets 2017 Gustavo Vazquez, Sebastian Camino, Leonardo Tondo et al.
Treatments for depression in bipolar disorder (BD) are far less well developed than for unipolar major depressive disorder. Several innovative and experimental approaches have been emerging recently, including use of the dissociative anesthetic ketamine and other antagonists of central NMDA glutamate receptors, as well as unsaturated fatty acids, anti-inflammatory agents, and possibly probiotic...
DOI: 10.2174/1871527316666170728165648 (opens in new tab)
Full text (opens in new tab)
Depression
Ketamine
Anti-inflammatory
Nmda receptor
+4